Molecularly Targeted therapeutic agents靶向治療藥品:~mab[]
main article: ~mab
unconjugated monoclonal antibody:腫瘤特異性抗體(tumor-specific antibody)[]
0
單株抗體偶聯物(Antibody conjugates)[]
抗體藥物複合體/單株抗體藥品偶聯物(Antibody-drug conjugates):由抗體導向的化學療法藥品 單株抗體結合毒殺藥物(antibody-drug conjugates, ADCs)[]
0
放射免疫治療(radioimmunotherapy)=單株抗體放射性同位素偶聯物(antibody-radionuclide conjugates, ARCs)[]
0
Molecularly Targeted therapeutic agents靶向治療藥品:Synthetic small molecule in targeted therapy標靶療法中的合成小分子:many are TK inhibitors or ~nibs : small molecules permeable to membrane inhibiting receptor's kinase ( ie. tyrosine kinase ) in the cytoplasm[]
main article: Synthetic small molecule in targeted therapy標靶療法中的合成小分子
unconjugated Synthetic small molecule(many are ~nib)[]
TKI[]
Serine/threonine kinase inhibitors (small molecules)[]
- Temsirolimus (Torisel)
- Everolimus (Afinitor)
- Vemurafenib (Zelboraf)
- Trametinib (Mekinist)
- Dabrafenib (Tafinlar)
- ...Serine/threonine-specific protein kinase inhibitor絲胺酸/蘇胺酸-專一性蛋白激酶抑制劑
others[]
- The selective estrogen receptor modulator tamoxifen has been described as the foundation of targeted therapy.
- ALK inhibitors, e.g. crizotinib
Small molecule drug conjugates[]
- Vintafolide is a small molecule drug conjugate consisting of a small molecule targeting the folate receptor. It is currently in clinical trials for platinum-resistant ovarian cancer (PROCEED trial) and a Phase 2b study(TARGET trial) in non-small-cell lung carcinoma (NSCLC).[1]
references[]
20170817wiki
Immunotherapy免疫療法[]
molecular Immunotherapy[]
a kind of targeted therapy
cellular Immunotherapy[]
Gene therapy(基因療法)[]
traditional classification[]
Chemotherapy:Alkylating agents(化學療法:烷化劑)[]
- 或稱烷基化劑
- alkylation through
- alkylation through carbocation
- alkylation through radical
- alkylation at what position
- interstrand cross-link
- intrastrand cross-link
Nitrogen mustards[]
aliphatic[]
- Nitrogen mustard N-oxide
- mechlorethamine
aromatic[]
- Melphalan
- Chlorambucil → Melphalan
micellaneous(其他):[]
- Cyclophosphamide (prodrug of phosphoramide mastard)→ phosphoramide mustard
- Ifosfamide (prodrug of ifosfamide mastard)
- Estramustine → Estramustine phosphate
- Estramustine phosphate
- phenoxybenzamine(別和phenbenzamine搞混): 治療pheocromocytoma
Aziridines[]
- Triethylenemelamine → Thiotepa
- Triethylenemelamine → Carboquone ← Mitomycin(Antineoplastics - agents from natural products)
Nitrosoureas : alkylation through carbocation : 常常脂溶性夠大而可以治療中樞神經癌症[]
chloroethylnitrosourea : O6 or N7 -alkylation of guanine nucleoties[]
- Methylnitrosoureas → Carmustine → Nimustine
- Methylnitrosoureas → Iomustine → Nimustine
不知道[]
- Nimustine
- Methylnitrosoureas → Iomustine → Semustine
- Streptozocin → Ranimustine
- Ranimustine
Procarbazine and triazenes: O6-methylation of guanine nucleoties with thymine→MMS(mis match repair system )[]
Procarbazine[]
Procarbazine→diazene intermediate : alkylation through radical
triazenes /Prodrug of MTIC : alkylation through carbocation[]
- Dacarbazine
- imidazolotetrazene der: Temozolomide
Alkyl sulfonate[]
- Busulfan : N7-methylation of guanine nucleoties
organoplatinum/Platinum coordination complex[]
- Cisplatin(生理食鹽水當作溶劑) N7-methylation of guanine nucleoties → Carboplatin → Nedaplatin
- Carboplatin(D5W當作溶劑) intrastrand cross-link between G and G
- Nedaplatin
- Cisplatin → Iproplatin
- Oxaliplatin
altratamine[]
Cytotoxic antibiotics抗生素[]
Toxic Food食物[]
Chemotherapy:Antimetabolic agents(化學療法:抗代謝)[]
indirect inhibitor of thymidylate synthase (Folic acid antagonists)[]
- Aminopterin
- Methotrexate:解毒劑是leucovorin(和5FU相反)
- Piritrexin
- Trimetrexate
- Raltitrexed
- Pemetrexed
direct inhibitor of thymidylate synthase : Pyrimidine analogue[]
- Fluorouracil(5FU)(prodrug)→FdUMP(active):加上leucovorin會增加毒性(和methotrexate相反)
- Tegafur(prodrug)
- Floxuridine(FUDR)(prodrug)→FdUMP(active)
- Doxifluridine
- Capecitabine(prodrug)
Purine antagonists : amidophosphoribosyl transferase inhibitors[]
- Mercaptopurine
- Thioguanine
- Thionosine
DNA polymerase/DNA chain elongation inhibitor[]
Pyrimidine analogue[]
Purine analogue : adenosine analogue[]
Others[]
- Azaserine
- Azacitidine
- DON
- EHNA
- Pentostatin(2'-deoxycoformycin)(DCF)
- Hydroxyurea
Chemotherapy:antibiotics(化學療法:抗生素)(破壞DNA)[]
alkylating agents(烷化劑)[]
radical[]
topoiisomerase Ⅱ inhibitor and radical[]
- Actinomycin D (Dactinomycin)
Topoisomerase Ⅱ inhibitor[]
Anthracyclines ( or Anthraquinone) and anthracenediones[]
屬於抗生素抗癌藥,結構類似tetracycline。2016NEJS臨床藥學- 報告用大圖:DOXORUBICIN引起的心毒性 DOXORUBICIN-INDUCED CARDIOTOXICITY
- Daunorubicin
- Doxorubicin(Adriamycin)
- Epirubicin
- valrubicin
- Idarubicin
- Pirarubicin
- Aclarubicin
anthracenediones[]
- Mitoxantrone
- piroxanthrone
其他[]
- menogaril
- Plicamycin(mithramycin)
- acivicin
- anthramycin
- Pentostatin(2'-deoxycoformycin)(DCF)
- calicheamicin
- Peplomycin
Chemotherapy:Agents from natural products=antibiotics+resin+alkaloids(化學療法:天然物=抗生素+樹脂+生物鹼)[]
alkylating agents(烷化劑)[]
radical[]
topoiisomerase Ⅱ inhibitor and radical[]
- Actinomycin D (Dactinomycin)
Topoisomerase Ⅱ inhibitor[]
Anthracyclines ( or Anthraquinone) and anthracenediones[]
屬於抗生素抗癌藥,結構類似tetracycline。
- Daunorubicin
- Doxorubicin(Adriamycin)
- Epirubicin
- valrubicin
- Idarubicin
- Pirarubicin
- Aclarubicin
anthracenediones[]
- Mitoxantrone
- piroxanthrone
Epipodophyllotoxins[]
屬於普達非倫衍生物,主要抑制topoisomerase Ⅱ。
- Podophyllin:為抗有絲分裂
- Podophyllotoxin:為抗有絲分裂
- Etoposide:為topoisomerase II inhibitor: 20110723台大醫學院團隊獨家破解常用化療老藥etoposide的抗癌和副作用機制
- Teniposide:為topoisomerase II inhibitor
Topoisomerase Ⅰ inhibitor(Camptothecins)[]
屬於喜樹鹼衍生物,主要抑制topoisomerase Ⅰ。
- Camptothecin
- Irinotecan
- Topotecan
micellaneous(其他抗生素)[]
- menogaril
- Plicamycin(mithramycin)
- acivicin
- anthramycin
- Pentostatin(2'-deoxycoformycin)(DCF)
- calicheamicin
- Peplomycin
Antimitotic[]
抑制有絲分裂
Epipodophyllotoxins[]
屬於普達非倫衍生物,主要抑制topoisomerase Ⅱ。
- Podophyllin:為抗有絲分裂
- Podophyllotoxin:為抗有絲分裂
- Etoposide:為topoisomerase II inhibitor
- Teniposide:為topoisomerase II inhibitor
marine natural product halichondrin B[1][2] from Halichondria genus of sponges[3][4][]
- Eribulin :為抗有絲分裂-a fully synthetic macrocyclic ketone analogue[1][2].
- cytotoxic mechanisms of action: apoptosis of cancer cells is induced following prolonged and irreversible mitotic blockade.[5][6]
- non-cytotoxic mechanisms of action:These non-mitotic mechanisms include vascular remodeling that leads to increased tumor perfusion and mitigation of tumor hypoxia, phenotypic changes consistent with reversal of epithelial-mesenchymal transition (EMT), and decreased capacity for migration and invasion leading to reduced metastatic capacity as measured in a preclinical experimental metastasis model.[7][8] In other studies, eribulin treatment of leiomyosarcoma and liposarcoma cells leads to increased expression of smooth muscle and adipocyte differentiation antigens, respectively.[9]
Enhancement of tubulin polymerization(Taxans紫杉醇)[]
促進聚合作用(與生物鹼抗癌藥不同)。
Tubulin polymerization inhibitor(Colchicine & Vinca alkaloids)[]
抑制聚合作用,生物鹼,Colchicine&長春花,屬於indole類,外滲熱敷,使用玻璃酸酶解毒。
- Colchicine
- Vinblastine
- Vincristine
- Vindesine
- Vinorelbine
other[]
Biologic response modifiers[]
- 荷爾蒙療法(Hormonestherapy)
- steroids
- retinoids
- immunotherapy
Male Breast carcinoma[]
testosterone
antiprogestin[]
mifepristone(RU486): treat progestone sensitive cancer,但無法治療攝護腺癌
Prostatic carcinoma[]
Progestin[]
- Chlormadinone acetate(Progestin)
Estrogen[]
- Diethylstilbestrol diphosphate(Estrogen)
- Estramustine
Antiandorogens[]
Corticoids inhibitor[]
- Aminoglutethimide(Aromatase inhibitor)
GnRH agonist[]
- Goserelin
- Leuprolide
- Triptoralen
GnRH antagonist[]
- abarelix
Breast carcinoma[]
Andorogen[]
- Fluoxymesterone
Progesterone receptor agonist(Progestins)[]
- Medroxyprogesterone acetate:可用於攝護腺癌
- Megestrol acetate:不可用於攝護腺癌
Corticoids inhibitor[]
Antiestrogens (SERM(slective estrogen receptor modulator))[]
- Tamoxifen → Toremifene
- Toremifene
- Raloxifene
- Epitiostanol —ProDrug→ Mepitiostane
- Mepitiostane
- Fulvestrant
Aromatase inhibitor[]
- Testolactone
- Letrozole
- Anastrozole
- Fadrozole
- Exemestane
Leukemia(Glucocorticoids)[]
- Meprednisone
- Prednisolone → Dexamethasone
- Dexamethasone
Thyroid carcinoma(Thyroid hormones)[]
- Liothyronine
- Levothyroxine
retinoid[]
immunotherapy免疫療法:好站介紹:卡斯柏的癌症免疫治療經驗分享[]
- Bacillus Calmette-Guerin(BCG)卡介苗
- interferon
- interferon alpha-2a
- interferon alpha-2b
- interferon alpha-n3
- aldesleukin
- denileukin diftitox(Ontak)
- levamisole
- thalidominde: treat 多發性骨髓瘤
- 胰臟癌新療法活化免疫系統 更新日期:2011/04/01 11:35【24drs.com】
- 當然,癌症是不會傳染的,它們是身體細胞經過某些特定的遺傳和突變而產生。即使如此,免疫系統應該能識別惡性細胞,因為它們表現出異常的分子片段,T細胞和B細胞應該會視其為外來物。然而,由於各種原因,免疫系統有時無法有效對抗癌症。這些年來,在強化免疫反應的努力獲得好壞參半的結果。近來,採用不同的策略已獲取更為一致的成功。事實證明,癌症有時會選擇關閉免疫系統的開關,積極抑制免疫系統對其生長擴張有所反應,而新的療法正是試圖移除這些煞車器。摘自: 召喚免疫軍團來抗癌! sa.ylib.com/MagCont.aspx?PageIdx=1&Unit=featurearticles&Cate=&id=2444&year=
Photodynamic therapy(PDT)[]
profimer sodium
micellaneous(未歸類)[]
Ethylenimines
Methylmelamines
Uracil mustard
pipobroman
amsacrine : 先嵌入DNA
suramin sodium
Gene therapy(基因療法)[]
基因療法:未來醫學 發展的重要方向之ㄧ,把正常的基因送到有疾病的人體內使之基因恢復正常而治療疾病,主要的問題在於:所送入的正常基因如何到達所需送達細胞之DNA的所欲送達位置,如果這個問題能解決,癌症、先天性缺陷等各種無法根治的疾病將可以被根治。解決這個問題的人得諾貝爾醫學獎絕對沒有問題,而且還可以賺大錢.
Targeted therapy(標靶藥物)[]
monoclonal antibody:bind to receptor[]
- cetuximab(Erbitux®)爾必得舒
- Panitumumab
- trastuzumab(Herceptin®)賀癌平
- Bevacizumab(Avastin®)癌思停
:Synthetic small molecule in targeted therapy標靶療法中的合成小分子:TK inhibitor: small molecules permeable to membrane inhibiting receptor's kinase ( ie. tyrosine kinase ) in the cytoplasm[]
- Imatinib(Glivec®)基利克
- gefitinib(Iressa®)艾瑞莎
- erlotinib(Tarceva®)得舒緩
- Lapatinib
- Sorafenib
- Sunitinib(SUTENT®)紓癌特
相關新聞[]
- 將研擬用於放寬包括降血脂藥物、乳癌標靶藥物「賀延平」、肺癌標靶藥物「艾瑞莎」、胃腸道基質瘤標靶藥物「基利克」、B、C肝炎及H1N1新型流感治療用藥等藥物之使用標準,目前為肺癌第二線標靶藥物的「艾瑞莎」等藥品,可望調整為第一線用藥,「基利克」更為「高貴」藥物第4名,民眾可望減輕自費買藥負擔。
- 乳癌標靶藥物「賀延平」、
- 肺癌標靶藥物「艾瑞莎」目前為肺癌第二線標靶藥物的「艾瑞莎」等藥品,可望調整為第一線用藥、
- 胃腸道基質瘤標靶藥物「基利克」,「基利克」更為「高貴」藥物第4名,民眾可望減輕自費買藥負擔。
New Taiwanese Antineoplastics classification[]

relation between antineoplastic, targeted therapy, ~mab,small molecule in targeted therapy and immunotherapy.

relations between targeted therapy、immunotherapyand Biological preparation.
增強防禦因子(increase immunity)[]
阻斷癌細胞關起免疫系統(block cancer cell to close immune system)[]
Checkpoint inhibitors檢查點抑制劑: PD-1 I:a targeted therapy, a molecular immunotherapy
刺激免疫系統對癌細胞的辨認(stimulate immune system to recognize cancer cell)[]
雙特異性抗體(bispecific antibodies):a targeted therapy, a molecular immunotherapy
使T細胞能辨認癌細胞(let T-cell can recognize cancer cell)[]
- 嵌合抗原受體重組T細胞(chimeric antigen receptor T-cell, CAR T cells):a cellular immunotherapy (2017年細胞免疫治療 (Chimeric Antigen Receptor T-cell immune therapy,CAR-T)進度)
降低攻擊因子(suppress tumor growth)[]
chemotherapy[]
Chemotherapy:Alkylating agents(化學療法:烷化劑)[]
- 或稱烷基化劑
- alkylation through
- alkylation through carbocation
- alkylation through radical
- alkylation at what position
- interstrand cross-link
- intrastrand cross-link
Nitrogen mustards[]
=aliphatic=[]
- Nitrogen mustard N-oxide
- mechlorethamine
=aromatic=[]
- Melphalan
- Chlorambucil → Melphalan
=micellaneous(其他):=[]
- Cyclophosphamide (prodrug of phosphoramide mastard)→ phosphoramide mustard
- Ifosfamide (prodrug of ifosfamide mastard)
- Estramustine → Estramustine phosphate
- Estramustine phosphate
- phenoxybenzamine(別和phenbenzamine搞混): 治療pheocromocytoma
Aziridines[]
- Triethylenemelamine → Thiotepa
- Triethylenemelamine → Carboquone ← Mitomycin(Antineoplastics - agents from natural products)
Nitrosoureas : alkylation through carbocation : 常常脂溶性夠大而可以治療中樞神經癌症[]
=chloroethylnitrosourea : O6 or N7 -alkylation of guanine nucleoties =[]
- Methylnitrosoureas → Carmustine → Nimustine
- Methylnitrosoureas → Iomustine → Nimustine
=不知道=[]
- Nimustine
- Methylnitrosoureas → Iomustine → Semustine
- Streptozocin → Ranimustine
- Ranimustine
Procarbazine and triazenes: O6-methylation of guanine nucleoties with thymine→MMS(mis match repair system )[]
= Procarbazine =[]
Procarbazine→diazene intermediate : alkylation through radical
= triazenes /Prodrug of MTIC : alkylation through carbocation =[]
- Dacarbazine
- imidazolotetrazene der: Temozolomide
Alkyl sulfonate[]
- Busulfan : N7-methylation of guanine nucleoties
organoplatinum/Platinum coordination complex[]
- Cisplatin(生理食鹽水當作溶劑) N7-methylation of guanine nucleoties → Carboplatin → Nedaplatin
- Carboplatin(D5W當作溶劑) intrastrand cross-link between G and G
- Nedaplatin
- Cisplatin → Iproplatin
- Oxaliplatin
altratamine[]
Cytotoxic antibiotics抗生素[]
Toxic Food食物[]
Chemotherapy:Antimetabolic agents(化學療法:抗代謝)[]
indirect inhibitor of thymidylate synthase (Folic acid antagonists)[]
- Aminopterin
- Methotrexate:解毒劑是leucovorin(和5FU相反)
- Piritrexin
- Trimetrexate
- Raltitrexed
- Pemetrexed
direct inhibitor of thymidylate synthase : Pyrimidine analogue[]
- Fluorouracil(5FU)(prodrug)→FdUMP(active):加上leucovorin會增加毒性(和methotrexate相反)
- Tegafur(prodrug)
- Floxuridine(FUDR)(prodrug)→FdUMP(active)
- Doxifluridine
- Capecitabine(prodrug)
Purine antagonists : amidophosphoribosyl transferase inhibitors[]
- Mercaptopurine
- Thioguanine
- Thionosine
DNA polymerase/DNA chain elongation inhibitor[]
=Pyrimidine analogue=[]
=Purine analogue : adenosine analogue=[]
Others[]
- Azaserine
- Azacitidine
- DON
- EHNA
- Pentostatin(2'-deoxycoformycin)(DCF)
- Hydroxyurea
Chemotherapy:antibiotics(化學療法:抗生素)(破壞DNA)[]
alkylating agents(烷化劑)[]
radical[]
topoiisomerase Ⅱ inhibitor and radical[]
- Actinomycin D (Dactinomycin)
Topoisomerase Ⅱ inhibitor[]
= Anthracyclines ( or Anthraquinone) and anthracenediones=[]
屬於抗生素抗癌藥,結構類似tetracycline。2016NEJS臨床藥學- 報告用大圖:DOXORUBICIN引起的心毒性 DOXORUBICIN-INDUCED CARDIOTOXICITY
- Daunorubicin
- Doxorubicin(Adriamycin)
- Epirubicin
- valrubicin
- Idarubicin
- Pirarubicin
- Aclarubicin
= anthracenediones =[]
- Mitoxantrone
- piroxanthrone
其他[]
- menogaril
- Plicamycin(mithramycin)
- acivicin
- anthramycin
- Pentostatin(2'-deoxycoformycin)(DCF)
- calicheamicin
- Peplomycin
Chemotherapy:Agents from natural products=antibiotics+resin+alkaloids(化學療法:天然物=抗生素+樹脂+生物鹼)[]
alkylating agents(烷化劑)[]
radical[]
topoisomerase Ⅱ inhibitor and radical[]
- Actinomycin D (Dactinomycin)
Topoisomerase Ⅱ inhibitor[]
= Anthracyclines ( or Anthraquinone) and anthracenediones=[]
屬於抗生素抗癌藥,結構類似tetracycline。
- Daunorubicin
- Doxorubicin(Adriamycin)
- Epirubicin
- valrubicin
- Idarubicin
- Pirarubicin
- Aclarubicin
= anthracenediones =[]
- Mitoxantrone
- piroxanthrone
= Epipodophyllotoxins =[]
屬於普達非倫衍生物,主要抑制topoisomerase Ⅱ。
- Podophyllin:為抗有絲分裂
- Podophyllotoxin:為抗有絲分裂
- Etoposide:為topoisomerase II inhibitor: 20110723台大醫學院團隊獨家破解常用化療老藥etoposide的抗癌和副作用機制
- Teniposide:為topoisomerase II inhibitor
Topoisomerase Ⅰ inhibitor(Camptothecins)[]
屬於喜樹鹼衍生物,主要抑制topoisomerase Ⅰ。
- Camptothecin
- Irinotecan
- Topotecan
micellaneous(其他抗生素)[]
- menogaril
- Plicamycin(mithramycin)
- acivicin
- anthramycin
- Pentostatin(2'-deoxycoformycin)(DCF)
- calicheamicin
- Peplomycin
Antimitotic[]
抑制有絲分裂
= Epipodophyllotoxins =[]
屬於普達非倫衍生物,主要抑制topoisomerase Ⅱ。
- Podophyllin:為抗有絲分裂
- Podophyllotoxin:為抗有絲分裂
- Etoposide:為topoisomerase II inhibitor
- Teniposide:為topoisomerase II inhibitor
=marine natural product halichondrin B[1][2] from Halichondria genus of sponges[3][4] =[]
- Eribulin :為抗有絲分裂-a fully synthetic macrocyclic ketone analogue[1][2].
- cytotoxic mechanisms of action: apoptosis of cancer cells is induced following prolonged and irreversible mitotic blockade.[5][6]
- non-cytotoxic mechanisms of action:These non-mitotic mechanisms include vascular remodeling that leads to increased tumor perfusion and mitigation of tumor hypoxia, phenotypic changes consistent with reversal of epithelial-mesenchymal transition (EMT), and decreased capacity for migration and invasion leading to reduced metastatic capacity as measured in a preclinical experimental metastasis model.[7][8] In other studies, eribulin treatment of leiomyosarcoma and liposarcoma cells leads to increased expression of smooth muscle and adipocyte differentiation antigens, respectively.[9]
= Enhancement of tubulin polymerization(Taxans紫杉醇) =[]
促進聚合作用(與生物鹼抗癌藥不同)。
= Tubulin polymerization inhibitor(Colchicine & Vinca alkaloids) =[]
抑制聚合作用,生物鹼,Colchicine&長春花,屬於indole類,外滲熱敷,使用玻璃酸酶解毒。
- Colchicine
- Vinblastine
- Vincristine
- Vindesine
- Vinorelbine
=other=[]
targeted therapy[]
unconjugated monoclonal antibody:腫瘤特異性抗體(tumor-specific antibody)-針對特定標靶的未接合型單株抗體,最初的targeted therapy MoAb屬此類[]
- unconjugated monoclonal antibody:腫瘤特異性抗體(tumor-specific antibody)
- 針對特定標靶的未接合型單株抗體,最初的targeted therapy MoAb屬此類。
單株抗體偶聯物(Antibody conjugates)[]
- 抗體藥物複合體/單株抗體藥品偶聯物(Antibody-drug conjugates)、單株抗體結合毒殺藥物(antibody-drug conjugates, ADCs)
- 單株抗體上接上藥品成為標靶藥品 :由抗體導向的化學療法藥品(Ab-chemotherapeutic conjugate):Antibody-drug conjugates抗體藥物複合體(摘自:15 年最值得期待的十項醫療創新應用作者 連 以婷 | 發布日期 2014 年 11 月 02 日 | 分類 精選 , 醫療科技)
- 放射免疫治療(radioimmunotherapy)=單株抗體放射性同位素偶聯物(antibody-radionuclide conjugates, ARCs)
- 單株抗體上接上放射性同位素成為標靶藥品
- 抗體藥物複合體/單株抗體藥品偶聯物(Antibody-drug conjugates)、單株抗體結合毒殺藥物(antibody-drug conjugates, ADCs)
unconjugated Synthetic small molecule(many are ~nib)[]
- TKI
- Serine/threonine kinase inhibitors (small molecules)
- others
Small molecule drug conjugates[]
- Vintafolide is a small molecule drug conjugate consisting of a small molecule targeting the folate receptor. It is currently in clinical trials for platinum-resistant ovarian cancer (PROCEED trial) and a Phase 2b study(TARGET trial) in non-small-cell lung carcinoma (NSCLC).[10]
Ab-chemotherapeutic conjugates:targeted therapy[]
.
Photodynamic therapy(PDT)[]
profimer sodium
miscellaneous(未歸類)[]
Ethylenimines
Methylmelamines
Uracil mustard
pipobroman
amsacrine : 先嵌入DNA
suramin sodium
抑制癌細胞轉移(metastasis inhibitor癌症轉移抑制劑 )[]
natural[]
- metastasis suppressor
artificial[]
修復突變的基因(replace mutated gene)-Gene therapy(基因療法)[]
基因療法:未來醫學 發展的重要方向之ㄧ,把正常的基因送到有疾病的人體內使之基因恢復正常而治療疾病,主要的問題在於:所送入的正常基因如何到達所需送達細胞之DNA的所欲送達位置,如果這個問題能解決,癌症、先天性缺陷等各種無法根治的疾病將可以被根治。解決這個問題的人得諾貝爾醫學獎絕對沒有問題,而且還可以賺大錢.
未整理完[]
Biologic response modifiers[]
- 荷爾蒙療法(Hormonestherapy)
- steroids
- retinoids
- immunotherapy
Male Breast carcinoma[]
testosterone
antiprogestin[]
mifepristone(RU486): treat progestone sensitive cancer,但無法治療攝護腺癌
Prostatic carcinoma[]
Progestin[]
- Chlormadinone acetate(Progestin)
Estrogen[]
- Diethylstilbestrol diphosphate(Estrogen)
- Estramustine
Antiandorogens[]
Corticoids inhibitor[]
- Aminoglutethimide(Aromatase inhibitor)
GnRH agonist[]
- Goserelin
- Leuprolide
- Triptoralen
GnRH antagonist[]
- abarelix
Breast carcinoma[]
Andorogen[]
- Fluoxymesterone
Progesterone receptor agonist(Progestins)[]
- Medroxyprogesterone acetate:可用於攝護腺癌
- Megestrol acetate:不可用於攝護腺癌
Corticoids inhibitor[]
Antiestrogens (SERM(slective estrogen receptor modulator))[]
- Tamoxifen → Toremifene
- Toremifene
- Raloxifene
- Epitiostanol —ProDrug→ Mepitiostane
- Mepitiostane
- Fulvestrant
Aromatase inhibitor[]
- Testolactone
- Letrozole
- Anastrozole
- Fadrozole
- Exemestane
Leukemia(Glucocorticoids)[]
- Meprednisone
- Prednisolone → Dexamethasone
- Dexamethasone
Thyroid carcinoma(Thyroid hormones)[]
- Liothyronine
- Levothyroxine
retinoid[]
immunotherapy免疫療法:好站介紹:卡斯柏的癌症免疫治療經驗分享[]
- Bacillus Calmette-Guerin(BCG)卡介苗
- interferon
- interferon alpha-2a
- interferon alpha-2b
- interferon alpha-n3
- aldesleukin
- denileukin diftitox(Ontak)
- levamisole
- thalidominde: treat 多發性骨髓瘤
- 胰臟癌新療法活化免疫系統 更新日期:2011/04/01 11:35【24drs.com】
- 當然,癌症是不會傳染的,它們是身體細胞經過某些特定的遺傳和突變而產生。即使如此,免疫系統應該能識別惡性細胞,因為它們表現出異常的分子片段,T細胞和B細胞應該會視其為外來物。然而,由於各種原因,免疫系統有時無法有效對抗癌症。這些年來,在強化免疫反應的努力獲得好壞參半的結果。近來,採用不同的策略已獲取更為一致的成功。事實證明,癌症有時會選擇關閉免疫系統的開關,積極抑制免疫系統對其生長擴張有所反應,而新的療法正是試圖移除這些煞車器。摘自: 召喚免疫軍團來抗癌! sa.ylib.com/MagCont.aspx?PageIdx=1&Unit=featurearticles&Cate=&id=2444&year=
see also[]
延伸學習[]

- 免疫抑制劑
- 抗癌藥和免疫抑制劑
- New Taiwanese Antineoplastics classification
- 抗癌藥
- TPN
- PCA
- CTC
- Chemotherapy(化學療法